Results 191 to 200 of about 273,933 (297)

Bilateral Adrenal Hemorrhage in Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Review of Mechanisms, Diagnosis, and Clinical Outcomes. [PDF]

Cureus
Pedraza Cruz P, Digiacomo D, Varghese M, Spencer CT.   +3 more
europepmc   +1 more source

Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

Arthritis &Rheumatology, Accepted Article.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin, Wenzhen Li, Xinyu A, Jun Shen, Xiaohui Meng, Yanqin Bian, Haihui Han, Zheng Xiang, Lei Ran, Songtao Sun, Jun Xie, Tao Yue, Qi Zhu, Xiaoming Zhang, Lu Xie, Lianbo Xiao   +15 more
wiley   +1 more source

Association between disease duration and comorbidity burden in systemic lupus erythematosus: a multicentre study from Pakistan. [PDF]

Lupus Sci Med
Tariq A, Sharif M, Ammar M.
europepmc   +1 more source

Molecular stratification of antiphospholipid syndrome through integrative analysis of the whole‐blood RNA transcriptome

Arthritis &Rheumatology, Accepted Article.
Objective Antiphospholipid syndrome (APS) is a thrombo‐inflammatory disorder characterized by clinical and mechanistic heterogeneity that complicates early diagnosis and hinders targeted treatment. We aimed to identify distinct molecular endotypes among antiphospholipid antibody (aPL)‐positive patients using whole‐blood transcriptomics.
Amala Ambati, Feiyang Ma, Katarina Kmetova, Sherwin Navaz, Claire K. Hoy, Cyrus Sarosh, Ajay Tambralli, Erika Navarro‐Mendoza, Johann E. Gudjonsson, J. Michelle Kahlenberg, Jacqueline A. Madison, Alí Duarte‐García, Jason S. Knight, Yu Zuo   +13 more
wiley   +1 more source

Hypertension and its complications in a young man with autoimmune disease [PDF]

, 2017
Basile, Jan N., Batlle, Daniel C., Dhaun, Neeraj, Dominiczak, Anna F., Elijovich, Fernando, Jennings, Garry L.R., Laffer, Cheryl L., Miller-Hodges, Eve, Oliveras, Anna, Oparil, Suzanne   +9 more
core   +1 more source

Practical insights for the clinical implementation of the EULAR recommendations for patients with systemic lupus erythematosus. [PDF]

RMD Open
Parodis I, Fanouriakis A, Bortoluzzi A, Iking-Konert C, Weinmann-Menke J, San Román C, Levy RA, Rua-Figueroa I, Alexander T, Amoura Z.   +9 more
europepmc   +1 more source

National Mortality Databases to Assess Disease Burden in Systemic Autoimmune Diseases: A Valuable Resource But With Limitations

Arthritis &Rheumatology, EarlyView.
Ram Raj Singh
wiley   +1 more source

A cooperative release of mitochondrial DNA from platelets and neutrophils drives an interferon signature in systemic sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective Mitochondria are organelles with a hypomethylated circular genome. Mitochondrial DNA (mtDNA) in the systemic circulation has been implicated in inflammation. This study investigates the role of circulating DNA in systemic sclerosis (SSc) and the cellular mechanisms governing its release.
Stavros Giaglis, André N. Tiaden, Simone Häner‐Massimi, Diego Kyburz, Cedric André, Anton Glück, Enrico Ferrero, Stuart Hawtin, Tobias Junt, Ulrich A. Walker   +9 more
wiley   +1 more source

LP-095 Macrophage activation in untreated patients with systemic lupus erythematosus (PRELIMINARY DATA)

Lupus Science and Medicine, 2023
Elena Gerasimova, Tatiana Popkova, Tatiana Kirichenko, Alexander Markin, Anastasia Bogatyreva   +4 more
doaj   +1 more source

Case Report: Relapsing systemic lupus erythematosus treated with dual rituximab and anifrolumab therapy. [PDF]

Front Med (Lausanne)
Lee S, Choi J, Benitez S, Lee J.
europepmc   +1 more source